Resmetirom tablet price

Resmetirom indicated for NASH patients with liver scarring FDA APPROVED resmetirom (Rezdiffra) over a computer rendering of a transparent

Madrigal Pharmaceuticals is pricing Rezdiffra (resmetirom) at wholesale acquisition price of $ per year.

The Institute for Clinical and Economic Review had assessed the health-benefit price benchmark for resmetirom to be between $39,600 and $50,100 per year. 3 Previously

After the first 30 patients were enrolled in the open-label 100 mg resmetirom arm, subsequent patients were randomized 1:1:1:1 to 3 double-blind arms (100 mg resmetirom, 80 mg resmetirom, or

Get a quote of Resmetirom API (CAS No. ) with Oral Solid/Tablets dose form Small molecule API technology under Therapeutic Category from the top global manufacturer supplier company. Resmetirom API Manufacturer and Supplier

Resmetirom treatment remained cost effective at a US$100,000 WTP threshold up to a daily price point of US$72.00.Conclusion Resmetirom is a potentially cost-effective treatment option for patients

Rezdiffra (resmetirom). The prices listed below Multiple forms of the same product (eg, tablets and capsules) are considered 1 product, and the prices.

Compare prices and print coupons for Resmetirom (Rezdiffra) and other drugs at CVS, Walgreens, and other pharmacies. Prices start at $3941.46.

price negotiation program on market entry of new drugs and The approved drug, resmetirom tablet, now branded as Rezdiffra